Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity - Wikidata - thesis-toulmin - TriplyDB

Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity

Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity

http://www.wikidata.org/entity/Q24633850

about

Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria Suppressor role of activating transcription factor 2 (ATF2) in skin cancer Rewired ERK-JNK signaling pathways in melanoma Induced ATF-2 represses CDK4 transcription through dimerization with JunD inhibiting intestinal epithelial cell growth after polyamine depletion Int6/eIF3e promotes general translation and Atf1 abundance to modulate Sty1 MAPK-dependent stress response in fission yeast Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis A role for ATF2 in regulating MITF and melanoma development.Emerging roles of ATF2 and the dynamic AP1 network in cancer.A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth RACK1 mediates activation of JNK by protein kinase C [corrected].Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2 Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell death Subtype and pathway specific responses to anticancer compounds in breast cancer.Genetic deletion of Cdc42GAP reveals a role of Cdc42 in erythropoiesis and hematopoietic stem/progenitor cell survival, adhesion, and engraftment.The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis Interfering with cancer: a brief outline of advances in RNA interference in oncology.Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells ATF2 - at the crossroad of nuclear and cytosolic functions.Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.ATF2 on the double - activating transcription factor and DNA damage response protein.Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex.Understanding signaling cascades in melanoma ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells.Infected erythrocyte-derived extracellular vesicles alter vascular function via regulatory Ago2-miRNA complexes in malaria.AP-1-mediated expression of brain-specific class IVa β-tubulin in P19 embryonal carcinoma cells Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy.Deregulation of AP-1 proteins in collagen gel-induced epithelial cell apoptosis mediated by low substratum rigidity.Expression and function of bcl-2 proteins in melanoma

P2860

Q21202829-E76D11A8-2BD3-49E6-8ACD-9E2AC80B0C2C Q24304390-83BCD47C-1204-4CB6-931E-EAFECEECAC02 Q24652406-FA4F4556-5524-4750-AD5B-78C1BA70C2BF Q24683737-41B6A05F-158D-4B12-A022-B02AC3223698 Q28573516-AEC1681A-C850-442A-B03B-14A652CE54F8 Q30482974-98DB5BCA-D224-4F7B-804A-12C42FFA84AF Q33305774-FA87B872-6B87-49D4-91FD-FE8ECF7A607A Q33569860-93A51B38-1C22-4BFF-8F44-AAF5797BB1CF Q33784589-1D333D68-2A02-44AF-B370-B26299A2BCEF Q33866973-4618A16D-0F26-48D2-AFC0-9FF01F012941 Q33999494-5E75476A-2156-4618-847A-E4B3481079DF Q34015919-449BAACE-A9CD-4C43-AEED-5BFCE9785A37 Q34191543-985D77ED-4C84-4575-919B-4D6FB4F8FCCA Q34669835-CB65975A-6F55-4D65-A7B1-6396066B7969 Q35293180-43F552C1-665B-47B9-A4CE-6CA9FEDE20AC Q35779241-2157B052-F664-4391-9BC4-93C65EF29298 Q35848504-6B5BA6C6-507B-48F7-9AD7-52C295FF047C Q35936631-67FD0EEF-E597-44C1-A8FF-056F6D6ACF65 Q35997754-A5F1BA02-BEAE-448F-979C-02544C4CB363 Q36095683-AA9D2BF9-4474-47FA-B5E4-DEF4A4CA2B5F Q36211955-F80A40F8-AE5B-4C84-9D01-C48097A7C28D Q36546659-C9D53211-FAB7-4938-98E4-8A0998C93511 Q36757582-2C025F02-755E-49CF-BD85-2349F833F7CB Q36957604-698906AA-16AD-449F-972E-17B4C987ECFF Q36970655-418B544F-AAA6-4335-AA8A-0B38AF78345B Q36978293-2B318000-892A-45FC-AC9F-FD6189024E71 Q37034487-B8D4737A-9B52-4664-88A5-1F42A951CECE Q37064522-5F5058C2-71FA-41BC-B118-A905ED3767AD Q37191024-FC634957-4F6A-4F42-9630-0A91608F7F44 Q37335988-A5B57357-7B82-4AAD-A03F-467AFF3ED258 Q38301269-33D1D665-3C02-4571-9CD6-B1DB46554FCE Q38904811-565E9394-C849-4ED8-B1F7-21371BB867D8 Q40211903-C41C1C62-9C34-4453-A202-B3CB176FCB12 Q41941878-B9432037-3191-4F7A-930C-F0D278FD5C3C

P2860

Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity

http://www.wikidata.org/entity/Q24633850

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Transcriptional switch by acti ...... inhibits their tumorigenicity

@ast

Transcriptional switch by acti ...... inhibits their tumorigenicity

@en

Transcriptional switch by acti ...... inhibits their tumorigenicity

@nl

type

label

Transcriptional switch by acti ...... inhibits their tumorigenicity

@ast

Transcriptional switch by acti ...... inhibits their tumorigenicity

@en

Transcriptional switch by acti ...... inhibits their tumorigenicity

@nl

prefLabel

Transcriptional switch by acti ...... inhibits their tumorigenicity

@ast

Transcriptional switch by acti ...... inhibits their tumorigenicity

@en

Transcriptional switch by acti ...... inhibits their tumorigenicity

@nl

P1433

Q24633850-326888B6-E01C-4F06-AAF5-6ABA59742123

P1476

Q24633850-29602BDE-27BD-43EB-B53C-1897963C2279

P2093

Q24633850-02AA8B92-5E67-4C96-90F4-10AFBEAB9917

Q24633850-A75F2D57-FCD9-4BE9-BCF2-CDBA267FB7DB

P2860

Q24633850-0684A244-D967-4BC7-A25A-6CB677CFE265

Q24633850-06E19893-2B71-4DCF-A5C4-6D63FE1B72E2

Q24633850-105A715A-72DD-4325-A95F-16216E2F858F

Q24633850-184DD0E4-E36F-4C94-9D1A-A9CF096FCEBD

Q24633850-1E35A81B-A864-47CE-A2F1-1EDDF5277D22

Q24633850-21E13F6A-0623-4D30-A1FD-435FEE4AEFA3

Q24633850-2657AB39-C78F-4C8D-820C-477C88380084

Q24633850-28B37D0C-CB30-471D-8C8C-DE668609EFF1

Q24633850-298B02D6-4AD6-40F4-9D4F-9C101618096B

Q24633850-2CC96603-59D1-4517-A3EC-B68F5704BF08

P304

Q24633850-040DE920-FA66-4B61-BC0D-C551DBFFF17F

P31

Q24633850-5AB24F11-5197-490B-A6A7-1D3411815139

P3181

Q24633850-9B00A87F-6D1C-4338-B191-1844CCB87E3D

P356

Q24633850-7772441B-0F1C-4050-9E36-A9D081A92718

P407

Q24633850-FD6938FB-5202-4763-A2FE-5695171898EB

P433

Q24633850-81DCF9F7-266C-4853-9DEE-D1E838F4BE28

P478

Q24633850-B092D5E1-95FE-4F54-914F-A0213C3511A0

P50

Q24633850-D469C477-43DE-44B7-A876-50C110A1849E

P577

Q24633850-DC28439F-0D80-4F8B-A5DE-E9E9C8789F76

P5875

Q24633850-D95709DD-FD6C-4482-8EAA-7E35C0DCE5A8

P698

Q24633850-6B6D06C6-979A-49C7-8F19-1B8B10B13FA0

P921

Q24633850-ACF2BC47-B68F-4CCB-9F38-DD6EACCE2EDA

P932

Q24633850-C4393534-0547-455D-B2E8-2D81009C10E7

P3181

P356

PNAS.0400195101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Transcriptional switch by acti ...... inhibits their tumorigenicity

@en

P2093

Anindita Bhoumik

http://www.w3.org/2001/XMLSchema#string

Nic Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface

A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.

Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation

RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization

Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines

Mutations of the BRAF gene in human cancer

Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2

P304

4222-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

265569

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0400195101

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5340412

http://www.w3.org/2001/XMLSchema#string

P698

15010535

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

384722

http://www.w3.org/2001/XMLSchema#string